Background
Chloe is an infectious diseases physician and clinical microbiologist who joined Burnet Institute in 2024 as a technical advisor in the AMR-One Health group.
She also works in infectious diseases and microbiology in Australian hospitals and is involved in research on antimicrobial resistance through the Wollongong Antimicrobial Resistance Research Alliance (WARRA).
Chloe has an interest in antimicrobial resistance, diagnostic stewardship, group A Streptococcal infections, microbial genomics, and development of microbiological services in low- and middle-income countries.
Qualifications
- 2023: Fellow of the Royal Australasian College of Physicians (Infectious Diseases)
- 2023: Fellow of the Royal College of Pathologists, Australasia (Microbiology)
- 2013: Bachelor of Medicine Bachelor of Surgery
- 2012: Honours Degree of Bachelor of Medical Science, First Class Honours, University of Adelaide
Appointments
- 2024–ongoing: Technical Advisor, Fleming Fund Country Grant (PNG), Burnet Institute
- 2023–ongoing: Staff Specialist in Microbiology, NSW Health Pathology - South, Wollongong Hospital
- 2023–ongoing: Honorary Clinical Lecturer, Graduate School of Medicine, University of Wollongong
- 2023: Member of the Papua New Guinea National Antimicrobial Guideline Writing Committee
Current projects
Tackling antimicrobial resistance in Papua New Guinea
By 2050, antimicrobial resistant bacteria (AMR) could cause 10 million deaths annually. Our collaborative project supports Papua New Guinea’s domestic AMR response.
Fleming Fund Country Grant: Papua New Guinea
Burnet Institute is leading the Papua New Guinea Country Grant component of the Fleming Fund, a UK Aid program tackling antimicrobial resistance in low- and middle-income countries.